# OnCo record jskn016 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/jskn016/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "jskn016" ;
  schema:name "JSKN016"@en ;
  schema:description "JSKN016 is an experimental drug that targets two proteins on cancer cells and carries chemotherapy. It has reached phase 3 testing; earlier response findings do not prove comparative benefit."@en ;
  schema:url <https://onco.cc/drugs/jskn016/> ;
  schema:dateModified "2026-10-06"^^xsd:date ;
  schema:citation <https://doi.org/10.1158/1557-3265.sabcs25-ps1-09-05>, <https://doi.org/10.1200/jco.2025.43.16_suppl.e13138>, <https://clinicaltrials.gov/study/NCT06592417>, <https://clinicaltrials.gov/study/NCT07533123> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "ADC" ;
  onco:cancers <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/breast-hr-positive/> ;
  onco:technologies <https://onco.cc/technologies/adc/>, <https://onco.cc/technologies/bispecific-adc/> ;
  onco:targets <https://onco.cc/targets/trop2/>, <https://onco.cc/targets/her3/> ;
  onco:companies <https://onco.cc/companies/alphamab/> ;
  onco:trials <https://onco.cc/trials/nct07533123/>, <https://onco.cc/trials/nct06942234/>, <https://onco.cc/trials/nct06592417/> .